Abpro Holdings, Inc. (ABPO) stock
ABPOOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as ABPWW
$0.41+0.00 (+0.11%)
Close on Oct 19, 2026Market cap $2.41MP/E –Yield –
Abpro ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Abpro's ebitda for the twelve months ending Jun 30, 2026 was -$5.33M. For fiscal 2025 it was -$8.43M.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$8.43M | – |
| FY2024 | Dec 31, 2024 | -$9.85M | – |
| FY2023 | Dec 31, 2023 | -$11.47M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$1.17M | – |
| Q1 FY2026 | Mar 31, 2026 | -$930.00K | – |
| Q4 FY2025 | Dec 31, 2025 | -$1.89M | – |
| Q3 FY2025 | Sep 30, 2025 | -$1.33M | – |
| Q2 FY2025 | Jun 30, 2025 | -$2.26M | – |
| Q1 FY2025 | Mar 31, 2025 | -$2.95M | – |
| Q2 FY2024 | Jun 30, 2024 | -$2.33M | – |
| Q1 FY2024 | Mar 31, 2024 | -$2.83M | – |
See a number that looks wrong?